Evidence map›Paper›PMID 37576528›Full record

ArticleThe International journal of angiology : official publication of the International College of Angiology, Inc2023

Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient.

Raka A Nugraha, Hary S Muliawan, Nyityasmono T Nugroho, Muhammad Ikhsan, Suko Adiarto

Abstract readCase Reports
In one paragraph

Article in The International journal of angiology : official publication of the International College of Angiology, Inc, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raka A NugrahaDepartment of General Medicine, Universitas Indonesia Hospital, Depok, Indonesia.ORCID 0000-0003-4822-5412
Hary S MuliawanDepartment of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita/Universitas Indonesia Hospital, Depok, Indonesia.
Nyityasmono T NugrohoDepartment of Vascular and Endovascular Surgery, Cipto Mangunkusumo Hospital/Universitas Indonesia Hospital, Depok, Indonesia.ORCID 0000-0001-8876-9698
Muhammad IkhsanDepartment of Internal Medicine, Cipto Mangunkusumo Hospital/Universitas Indonesia Hospital, Depok, Indonesia.
Suko AdiartoDepartment of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita/Universitas Indonesia Hospital, Depok, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been a global burden associated with significant morbidity and mortality. COVID-19 has been correlated with the development of hypercoagulable state that predisposes the patients to a higher risk of thromboembolism. Current evidence suggests higher incidence of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients, mostly with critical illness. On the other hand, there is currently no data regarding the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare. Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous thrombosis in a patient with mild COVID-19. This report highlights the occurrence of concomitant arterial and venous thrombosis in ambulatory setting and that this phenomenon resulted in catastrophic clinical consequences.

Indexed as

acute limb ischemiaambulatoryanticoagulationdeep vein thrombosisischemia-reperfusion injurymild COVID-19thrombectomy

Identifiers

PMID37576528
PMCPMC10421675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.